Delivery Order SPE2DB20D1100-SPE2DB24FC3Y4

Award Date 6/24/24
Potential Completion Date 6/25/24
Potential Value $3.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $7,604.13 and a completion date of April 23, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $4,009.36 delivery order has a completion date of June 7, 2024 and is a firm fixed price contract. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical for up to $999,999,999.00 to provide a comprehensive range of pharmaceutical...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, is for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML to the Defense Logistics Agency (DLA) under a Delivery Order valued at $3,308.04. The contract has a firm fixed price and an ultimate completion date of May 21, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division provides $3,364.68 for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a prescription medication, to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $3,364.68 and an ultimate completion date of June 7, 2024. This is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 31,...
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, is for the delivery of 4565083282 TRULICITY 3 MG/0.5 ML PEN 0.5ML. The contract, valued at $2,031.96, is a firm fixed price Delivery Order awarded by the Defense Logistics Agency (DLA), a defense agency. The contract has a completion date of July 9, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 31,...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,612.52 firm fixed price contract has a completion date of June 28, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The ceiling value of the contract is $1,015.98. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, was issued by the Defense Logistics Agency (DLA) for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML pharmaceutical products. The single-award Indefinite Delivery Contract (IDC) has a ceiling value of $1,741.68 and a period of performance through April 22, 2024. This contract is part of Amerisourcebergen's larger $999,999,999.00 IDC with the DLA Troop Support Medical, which serves as the primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML pharmaceutical product. The $1,741.68 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency that provides logistics, acquisition, and technical services to the U.S. Armed Forces. The award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order valued at $2,177.10 for the supply of the pharmaceutical product TRULICITY 3 MG/0.5 ML PEN 0.5ML. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of June 25, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FC3Y4
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $3,773.64 and a period of performance ending on June 25, 2024. This is a delivery order contract with a firm fixed price pricing type. Amerisourcebergen holds a larger, single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation.

Generated 9/23/24, 10:08 AM